Literature DB >> 15897750

Peripheral bile duct paucity and cholestasis in the liver of a patient with Alagille syndrome: further evidence supporting a lack of postnatal bile duct branching and elongation.

Louis Libbrecht1, Nancy B Spinner, Elizabeth C Moore, David Cassiman, Rita Van Damme-Lombaerts, Tania Roskams.   

Abstract

Alagille syndrome (AGS) is a developmental, multiorgan disease caused by mutations of the Jagged1 gene. The liver is one of the major organs affected in AGS, and the hallmark of liver pathology in AGS is an age-related increase in the proportion of portal tracts that have no bile duct, but without evidence of prominent bile duct damage. The pathogenesis of this bile duct paucity is currently not well understood. (Immuno)histochemical and molecular analyses were performed on several liver biopsies that were taken during macroscopic examination of the explant liver of a 17-year-old AGS patient. The liver periphery was macroscopically pale and was microscopically characterized by complete absence of bile ducts and presence of severe cholestasis, but there was no ductular reaction. Conversely, the central, hilar portion contained normally developed bile ducts showing no or minimal damage and cholestasis. A missense mutation in the Jagged1 gene was present in both parts of the liver, indicating that mosaicism did not cause this peculiar picture. There was also a hypertrophy of the hepatic arterial branches in the liver periphery. Together with previous indirect findings, the current study of the explant liver of an AGS patient strongly suggests that a lack of branching and elongation of bile ducts during postnatal liver growth is the mechanism by which peripheral bile duct paucity and cholestasis develops in AGS. Our findings also suggest that anomalies of the intrahepatic arterial branches may be part of AGS in some patients.

Entities:  

Mesh:

Year:  2005        PMID: 15897750     DOI: 10.1097/01.pas.0000161325.36348.25

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  17 in total

Review 1.  Emerging concepts in biliary repair and fibrosis.

Authors:  Luca Fabris; Carlo Spirli; Massimiliano Cadamuro; Romina Fiorotto; Mario Strazzabosco
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-19       Impact factor: 4.052

2.  Frequency and pathogenesis of central liver nodules in Alagille syndrome patients.

Authors:  Louis Libbrecht; David Cassiman
Journal:  Pediatr Radiol       Date:  2017-05-04

3.  Frequency and pathogenesis of central liver nodules in Alagille syndrome patients: Reply to Libbrecht and Cassiman.

Authors:  Jordan B Rapp; Richard D Bellah; Carolina Maya; Bruce R Pawel; Sudha A Anupindi
Journal:  Pediatr Radiol       Date:  2017-05-06

4.  Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome.

Authors:  Joshua M Adams; Kari A Huppert; Eumenia C Castro; Mario F Lopez; Nima Niknejad; Sanjay Subramanian; Neda Zarrin-Khameh; Milton J Finegold; Stacey S Huppert; Hamed Jafar-Nejad
Journal:  Hepatology       Date:  2020-01-24       Impact factor: 17.425

5.  Human hepatic organoids for the analysis of human genetic diseases.

Authors:  Yuan Guan; Dan Xu; Phillip M Garfin; Ursula Ehmer; Melissa Hurwitz; Greg Enns; Sara Michie; Manhong Wu; Ming Zheng; Toshihiko Nishimura; Julien Sage; Gary Peltz
Journal:  JCI Insight       Date:  2017-09-07

6.  Nodular macroregenerative tissue as a pattern of regeneration in cholangiopathic disorders.

Authors:  Preston Roberts; Andrew T Trout; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2018-04-19

Review 7.  Ductal plates in hepatic ductular reactions. Hypothesis and implications. III. Implications for liver pathology.

Authors:  Valeer J Desmet
Journal:  Virchows Arch       Date:  2011-02-08       Impact factor: 4.064

Review 8.  [Cholestasis-associated hepatopathies in neonates and infants].

Authors:  G Knöpfle; A Adam; H-P Fischer
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

9.  Notch signaling regulates formation of the three-dimensional architecture of intrahepatic bile ducts in mice.

Authors:  Erin E Sparks; Kari A Huppert; Melanie A Brown; M Kay Washington; Stacey S Huppert
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

10.  Hedgehog pathway and pediatric nonalcoholic fatty liver disease.

Authors:  Marzena Swiderska-Syn; Ayako Suzuki; Cynthia D Guy; Jeffrey B Schwimmer; Manal F Abdelmalek; Joel E Lavine; Anna Mae Diehl
Journal:  Hepatology       Date:  2013-04-01       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.